文献速递乳腺MR

扩散峰度成像直方图分析鉴别乳腺良恶性病变

Histogram analysis of diffusion kurtosis imaging in the differentiation of malignant from benign breast lesions.
PubMed 文献 · Eur J Radiol · 2019-06-17

本回顾性研究纳入71例患者共72个经病理证实的乳腺病变(良性30个、恶性42个),采用3.0T DWI(b值0、500、800、2000 s/mm²)和DCE-MRI,对全病变行ADC与DKI参数(D、K)直方图分析。恶性病变ADC和D的均值、中位数及第10/25/75百分位数显著低于良性,偏度显著高于良性;K的均值、中位数及第10/25/75/90百分位数显著高于良性。第75百分位K联合第10百分位D的Az为0.937,诊断敏感度85.71%、特异度93.33%。

要点

  • 恶性乳腺病变ADC与D各直方图参数普遍低于良性、K各直方图参数普遍高于良性,反映组织异质性。
  • 第75百分位K的Az为0.904,高于第10百分位ADC的Az 0.752,两者差异有统计学意义(p=0.0321)。
  • 第75百分位K联合第10百分位D的Az为0.937,敏感度85.71%、特异度93.33%。

核心结论

  • DKI直方图分析能准确反映乳腺病变的组织学特征与异质性,是诊断乳腺病变的可靠方法。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准,纳入71例患者共72个经组织病理学证实的乳腺病变(良性30个、恶性42个)。
  • 采用3.0T扩散加权成像(DWI),b值取0、500、800、2000 s/mm²,并行动态对比增强磁共振成像(DCE-MRI)。
  • 使用FireVoxel软件对整个病变行常规DWI与DKI直方图分析,参数包括表观扩散系数(ADC)、扩散系数(D)和峰度(K)。
  • 采用受试者工作特征(ROC)回归模型分析ADC与DKI参数(D、K)诊断乳腺病变的效能。

关键影像表现/征象

  • 恶性病变ADC和D的均值、中位数及第10/25/75百分位数显著低于良性病变(均p<0.05),ADC和D的偏度显著高于良性病变(均p<0.05)。
  • 恶性病变K的均值、中位数及第10/25/75/90百分位数显著高于良性病变(均p<0.05)。

诊断标准与关键数值

  • 各参数组内,第10百分位ADC(Az=0.752)、第10百分位D(Az=0.834)与第75百分位K(Az=0.904)是鉴别乳腺良恶性病变的最佳指标。
  • 第75百分位K的Az显著高于第10百分位ADC(p=0.0321)。
  • 第75百分位K联合第10百分位D的Az为0.937,显著高于第10百分位D(p=0.0097)和平均K(p=0.0431)。
  • 第75百分位K联合第10百分位D的诊断敏感度为85.71%、特异度为93.33%。

临床应用与阅片要点

  • 阅片时可对全病变行DKI直方图分析,重点关注第75百分位K与第10百分位D及其联合模型。
  • 恶性病变ADC与D直方图参数偏低、K直方图参数偏高,报告中可结合这些直方图特征描述病变异质性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To assess the diagnostic accuracy of histogram analysis of diffusion kurtosis imaging (DKI) in breast lesions.

MATERIALS AND METHODS: Our institutional review board approved this retrospective study. Seventy-two breast lesions (30 benign and 42 malignant) in 71 patients were histopathologically confirmed. All breast lesions were evaluated by 3.0-T diffusion-weighted imaging (DWI) with 4 b-values of 0, 500, 800, and 2000s/mm2 and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Histogram analyses of conventional DWI and DKI were performed using FireVoxel software for whole lesions. The parameters included apparent diffusion coefficient (ADC), diffusivity (D), and kurtosis (K). The metrics of ADC and DKI parameters (D and K) for benign lesions were compared with those for malignant lesions. The effectiveness of the ADC and DKI parameters (D and K) for diagnosing breast lesions was analysed using receiver operating characteristic (ROC) regression models.

RESULTS: For the malignant breast lesions, the mean, median, and 10th/25th/75th percentile values of ADC and D were significantly lower, while the skewness of ADC and D were significantly higher in comparison of the benign lesions(all p < 0.05). The malignant lesions had significantly higher mean, median, and 10th/25th/75th/90th percentile K values than did the benign lesions (all p < 0.05). Within each set of parameters, the 10th percentile ADC (Az = 0.752) and D, (Az = 0.834) coupled with the 75th percentile K (Az = 0.904) were the best metrics for differentiating benign from malignant breast lesions. After comparing the parameters in pairs, the Az for the 75th percentile K was significantly higher than that for the 10th percentile ADC (p = 0.0321) in differentiating benign from malignant breast lesions. When comparing the combination of the 75th percentile K and the 10th percentile D (Az = 0.937) with the 10th percentile D, 75th percentile K and the mean K, a significantly higher Az was observed for the combination than that for the 10th percentile D and the mean K (p = 0.0097 and p = 0.0431, respectively). The diagnostic sensitivity and specificity of the combination of the 75th percentile K and the 10th percentile D were 85.71% and 93.33%, respectively.

CONCLUSION: Histogram analysis of DKI can accurately reflect the histologic characteristics and heterogeneity and is a reliable method for diagnosing breast lesions.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Liu W, Wei C, Bai J, et al. Histogram analysis of diffusion kurtosis imaging in the differentiation of malignant from benign breast lesions. Eur J Radiol. 2019. PMID: 31307642. doi:10.1016/j.ejrad.2019.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。